Q&A With Monika Fischer From Indiana University: Tackling New Challenges In Gastroenterology

Video

Patients with irritable bowel disease can have enough issues to deal with in their daily lives. Add a condition like c-diff can make the treatment that much more complicated.

Patients with irritable bowel disease can have enough issues to deal with in their daily lives. Add a condition like c-diff can make the treatment that much more complicated.

Monika Fischer, MD, from Indiana University discussed some of the latest research in this field during the annual meeting of the American College of Gastroenterology in Hawaii.

As fecal microbiota transplant becomes a more common procedure to treat patients with gastrointestinal issues new questions are being answered about factors that can affect its success.

Related Videos
Prashant Singh, MD | Credit: University of Michigan
Noa Krugliak Cleveland, MD | Credit: University of Chicago
Ali Rezaie, MD | Credit: X
Remo Panaccione, MD | Credit: University of Calgary
Francisca Joly, MD, PhD | Credit: The Transplantation Society
Paul Feuerstadt, MD | Yale School of Medicine
| Image Credit: LinkedIn
Oriana Damas, MD | Credit University of Miami
Ali Rezaie, MD | Credit: X
Michael Todd Dolinger, MD | Credit: Mount Sinai
© 2024 MJH Life Sciences

All rights reserved.